Literature DB >> 17027360

Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome.

Michael H Dahan1, Jerald Goldstein.   

Abstract

OBJECTIVE: To evaluate the relationship between serum sex hormone-binding globulin (SHBG) and parameters of insulin sensitivity in women with polycystic ovary syndrome (PCOS) and controls, and determine the feasibility of using SHBG levels to predict insulin resistance.
DESIGN: Evaluation of a prospectively collected database.
SETTING: University reproductive center. PATIENT(S): A total of 21 women with PCOS and 17 controls. INTERVENTION(S): Oral glucose tolerance test. MAIN OUTCOME MEASURE(S): Correlations of serum SHBG and parameters of insulin sensitivity. RESULT(S): [1] Among all participants, SHBG levels indicated a correlation between the fasting glucose-to-insulin (GI) ratio and the quantitative insulin sensitivity check index (QUICKI). Participants with PCOS demonstrated significant correlations of SHBG and fasting GI ratio, 1-hour postglucola insulin levels, and random 17-hydroxyprogesterone (17ohP4) levels. Among controls, SHBG and fasting serum glucose and 2-hour postglucola serum glucose levels were associated. [2] Participants with PCOS and lean controls exhibited different glucose and insulin responses to 75 g of glucose at 1 and 2 hours postchallenge, resulting in paradoxically similar GI ratios. CONCLUSION(S): [1] Although certain parameters of insulin status and serum SHBG demonstrated statistically significant correlation coefficients, these relationships are weak and SHBG cannot be used as a predictor of insulin resistance. [2] The post-glucose load GI ratio cannot be used to determine the magnitude of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027360     DOI: 10.1016/j.fertnstert.2006.02.108

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

Authors:  D Micic; M Sumarac-Dumanovic; A Kendereski; G Cvijovic; S Zoric; D Pejkovic; J Micic; N Milic; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

2.  The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome.

Authors:  A Michael Wallace; Naveed Sattar
Journal:  Clin Biochem Rev       Date:  2007-08

3.  Sex-specific Associations of Sex Hormone Binding Globulin with CKD and Kidney Function: A Univariable and Multivariable Mendelian Randomization Study in the UK Biobank.

Authors:  Jie V Zhao; C Mary Schooling
Journal:  J Am Soc Nephrol       Date:  2020-12-14       Impact factor: 10.121

4.  Post-glucose insulin level in polycystic ovarian syndrome.

Authors:  Somsri Wiwanitkit; Viroj Wiwanitkit
Journal:  J Hum Reprod Sci       Date:  2011-09

5.  Authors' reply.

Authors:  Pikee Saxena; Anupam Prakash; Aruna Nigam
Journal:  J Hum Reprod Sci       Date:  2011-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.